Literature DB >> 12794416

Circulating vasopressin levels in septic shock.

Tarek Sharshar1, Anne Blanchard, Michel Paillard, Jean Claude Raphael, Philippe Gajdos, Djillali Annane.   

Abstract

OBJECTIVE: To assess the frequency of vasopressin deficiency in septic shock.
DESIGN: Prospective cohort study.
SETTING: Intensive care unit at Raymond Poincaré University Hospital. PATIENTS: A cohort of 44 patients who met the usual criteria for septic shock for < 7 days. A second cohort of 18 septic shock patients were enrolled within the first 8 hrs of disease onset.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: General demographics, severity scores, vital signs, standard biochemical data, and circulating vasopressin levels were systematically obtained at baseline in the two cohorts. Vasopressin deficiency was defined by a normal plasma vasopressin level in the presence of a systolic blood pressure of <100 mm Hg or in the presence of hypernatremia. Baroreflex sensitivity was systematically evaluated in patients of the first cohort when vasopressin deficiency was noted. In the second cohort of patients, plasma levels of vasopressin were obtained at baseline, 6, 24, 48, and 96 hrs after shock onset. In the first population, plasma vasopressin levels were inversely correlated to the delay from shock onset. Fourteen patients had relative vasopressin deficiency: 12 patients had systolic blood pressure <100 mm Hg, with impaired baroreflex sensitivity in four, and three patients had hypernatremia. In the second population, only two patients had relative vasopressin deficiency. The plasma levels of vasopressin significantly decreased over time (p < 10-3).
CONCLUSIONS: Plasma vasopressin levels are almost always increased at the initial phase of septic shock and decrease afterward. Relative vasopressin deficiency is seen in approximately one-third of late septic shock patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794416     DOI: 10.1097/01.CCM.0000063046.82359.4A

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  79 in total

1.  Comment on "Role of vasopressin in the management of septic shock" by Mutlu and Factor.

Authors:  Martin W Dünser; Andreas J Mayr; Volker Wenzel; Walter R Hasibeder
Journal:  Intensive Care Med       Date:  2004-07-23       Impact factor: 17.440

2.  Impact of low-dose vasopressin on trauma outcome: prospective randomized study.

Authors:  Stephen M Cohn; Janet McCarthy; Ronald M Stewart; Rachelle B Jonas; Daniel L Dent; Joel E Michalek
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

3.  Multiple alpha1-adrenergic receptor subtypes support synergistic stimulation of vasopressin and oxytocin release by ATP and phenylephrine.

Authors:  Zhilin Song; Dayane A Gomes; Wanida Stevens; Celia D Sladek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-09-29       Impact factor: 3.619

Review 4.  Differential signaling in presynaptic neurotransmitter release.

Authors:  Wim E J M Ghijsen; A G Miriam Leenders
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

Review 5.  Sepsis: a clinical update.

Authors:  Corey E Ventetuolo; Mitchell M Levy
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-07       Impact factor: 8.237

6.  Could hyponatremia be a marker of anastomotic leakage after colorectal surgery? A single center analysis of 1,106 patients over 5 years.

Authors:  S A Käser; U Nitsche; M Maak; C W Michalski; C Späth; T C Müller; C A Maurer; K P Janssen; J Kleeff; H Friess; F G Bader
Journal:  Langenbecks Arch Surg       Date:  2014-05-23       Impact factor: 3.445

7.  Increased levels of pro-AVP and pro-ADM in septic shock patients: what could it mean?

Authors:  Antoine Roch
Journal:  Intensive Care Med       Date:  2009-08-07       Impact factor: 17.440

8.  Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients.

Authors:  Caroline Guignant; Nicolas Voirin; Fabienne Venet; Françoise Poitevin; Christophe Malcus; Julien Bohé; Alain Lepape; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2009-08-07       Impact factor: 17.440

9.  Nephroprotective strategies in septic shock: the VANISH trial.

Authors:  Sophia Kwon; George Crowley; Syed Hissam Haider; Liqun Zhang; Anna Nolan
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

10.  Phosphoinositide 3-Kinase Is Involved in Mediating the Anti-inflammation Effects of Vasopressin.

Authors:  Woan-Ching Jan; Ming-Chang Kao; Chen-Hsien Yang; Ya-Ying Chang; Chun-Jen Huang
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.